Letters Section Editor: Jody W. Zylke, MD, Senior Editor.
Author Affiliations: Department of Medicine, Hualien Armed Forces General Hospital, Hualien, Taiwan (Dr Lin; firstname.lastname@example.org); Department of Public Health, Tzu-Chi University, Hualien, Taiwan (Dr Li); and Department of Medicine, Taipei Veterans General Hospital, Taipei, Taiwan (Dr Han).
To the Editor: Dr Andersson and colleagues1 reported that among patients with diabetes compared with patients without diabetes, the use of conventional clopidogrel treatment after myocardial infarction (MI) was associated with lower reduction in the risk of all-cause death and cardiovascular death. However, we wonder whether there were differences in mortality by sex.
Lin G, Li Y, Han C. Treatment With Clopidogrel After Myocardial Infarction. JAMA. 2012;308(23):2456-2457. doi:10.1001/jama.2012.28718